Navigation Links
Vivex Biomedical and Akron Biotech: Collaborative Venture in Regenerative Medicine
Date:8/7/2014

BOCA RATON, Fla., Aug. 7, 2014 /PRNewswire/ -- Akron is pleased to announce that it secured a strategic collaboration with Vivex Biomedical, Inc. on the use of its next-generation line of cryopreservation media, CryoNovo™.

Vivex Biomedical, Inc., from Marietta, GA, designs and develops innovative biologic products for regenerative medicine applications. Tracy Anderson, Vivex CEO, speaks to the imperative, "Vivex underscores its commitment to patient care in the confidence that only the highest quality products become therapeutic options. Our collaboration with Akron Biotech meets those standards of excellence."

Akron's glycerol-, serum- and DMSO-free cryoprotectant, CryoNovo™ T82, was developed as a non-toxic alternative to traditional DMSO-based cryopreservation media. CryoNovo™ T82 provides improved cell viability and functionality when used to preserve biological cells and tissues.

Akron's Claudia Zylberberg said, "We are extremely pleased to extend our new line of DMSO-free cryomedia toward exciting and important new applications, and the collaboration with Vivex is a prime example of the potential and significance of improved cryopreservation solutions which Akron pioneered."

CryoNovo™ T82 is used in the Vivex process of viable bone allograft preparation; retaining cell function, sustaining cell viability, and providing dependable cell identity that supports therapeutic intervention in orthopaedic and other regenerative medicine applications.

About Akron Biotech
Akron Biotech was founded in 2006, and is a privately owned company headquartered in South Florida, U.S. Akron has a strategic focus on delivering biological materials, technologies, and services for the regenerative medicine industry. As a global supplier, Akron manufactures components and specialized raw materials for cell therapy discovery, development, and commercialization, meeting the industry's needs worldwide. Our company's unique business model emphasizes flexibility, quality, and unparalleled service—from research and development to commercialization.

About Vivex Biomedical
Vivex Biomedical, Inc. is a biomaterials and human tissue manufacturer, distributor and developer located in Marietta, Georgia.  Vivex is a pioneer and an innovator in the field of biomaterials and regenerative medicine that focuses on improving treatment options through engineered solutions that advance the clinical, surgical, and therapeutic care of patients. Vivex sets to raise a new standard in patient care through innovative health products delivered to meet the needs of a diverse and rapidly expanding population of patients that seek tissue repair over replacement as a management strategy for their healthcare issues.


'/>"/>
SOURCE Vivex Biomedical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
2. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
3. Fluke Biomedical launches speedy new ProSim™ SPOT Light SpO2 Functional Tester
4. Fluke Biomedical device first to achieve environmentally-friendly label
5. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
6. The Biomedical Device Industry in America: Challenges at Home and Abroad
7. Carnegie Mellon University Biomedical Engineers Lead Collaborative Team Developing New Astro Surgery Tools for NASA Deep Space Missions
8. KalVista Pharmaceuticals Wins £2.4m Biomedical Catalyst Grant to Further Develop Oral Plasma Kallikrein Inhibitors as a Treatment for Diabetic Macular Edema
9. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
10. Fluke Biomedical launches simple, portable, efficient VT305 Gas Flow Analyzer
11. FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017 According to a new market research ... R&D, Compliance, SCM), Component (Software, Service), Delivery (On premise, Cloud), End ... by MarketsandMarkets, the market is expected to reach USD 24.73 Billion ... of 13.3% during the forecast period. ... ...
(Date:1/21/2017)...  Faruqi & Faruqi, LLP, a leading national securities law ... (NASDAQ: KMPH ) of the federal securities class ... directors and underwriters of the Company,s April 16, 2015 Initial ... plaintiff. The lawsuit has been filed in the ... Johnson County on behalf of all those who ...
(Date:1/20/2017)... , January 20, 2017 Stock-Callers.com today ... SGYP ), Novo Nordisk A/S (NYSE: ... and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX ). ... Thursday, January 19 th , 2017, finishing near its session ... Index dropped over 0.7%, while shares of health care companies ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... , ... “Life Under Blankets”: an entrancing story about one woman's travels ... is the creation of published author, Kimberly Mitchell, who earned her bachelor’s degree in ... to pursue a master’s degree in education in the field of curriculum and instruction. ...
(Date:1/23/2017)... ... ... Valentine’s Day is a time when many people celebrate romance and love by giving cards, ... for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s Day ... $200 and get $50 free. , “A lot of people just buy the more ...
(Date:1/22/2017)... (PRWEB) , ... January 22, 2017 , ... Zifam Pinnacle, ... across the world, recently met with big-name retail buyers at the January ECRM Trade ... of efficacy and uses the utmost safety standards in all of its creations to ...
(Date:1/22/2017)... ... 2017 , ... Medical lab testing through hospitals and other traditional ... test will take days to arrive to the end customer, having to travel through ... their lab tests, bypassing the cost and delay of traditional means. Now all employees ...
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... from Germany, announced it is bringing its product to the United States as part ... perfected over the last 25 years, Alcovit aims to reduce the productions of nasty ...
Breaking Medicine News(10 mins):